Dynamics of the Urinary Bacterial Microbiota
NCT07020676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2025-10-01
Summary
Urinary tract infections (UTIs) are one of the most common bacterial infections in humans (Flores-Mireles et al., 2015). They rank first among healthcare-associated infections (Daniau et al., 2020) and second among community-acquired infections. Their diagnosis is based on the presence of urinary symptoms, confirmed by performing a urine culture culture (UCEC), which consists of collecting the patient's bladder urine. Urine samples are generally considered sterile when they do not allow the identification of uropathogenic bacteria using standard clinical culture procedures (Caron et al., 2018). However, conventional urine culture has low sensitivity, with the rate of positive urine cultures in patients with acute cystitis being estimated at 60% (Schmiemann et al., 2010). It is now established that urine has its own microbiota, that is, a set of microorganisms residing in the bladder, most of which are not cultivable under conventional laboratory conditions.
The relationship between the dynamics of urinary microbiota composition and the pathobiology of UTIs is beginning to be studied in humans (Neugent et al., 2020). Price et al. analyzed the urine of women with UTI symptoms using EQUC culture, compared to a symptom-free control group (Price et al., 2016). More precise identification of cultured bacteria revealed the presence of bacteria that were not detected using conventional culture (such as Lactobacillus iners, Gardnerella vaginalis, Prevotella sp., and Aerococcus urinae). In addition, sequencing allowed the characterization of polymicrobial communities, present in many of the samples analyzed.
These findings have led to a significant revision of the traditional perception of UTIs. It has thus been suggested that, following a disruption in the homeostasis of the urinary microbiota (urinary dysbiosis), certain bacteria considered commensals of the urinary tract can become pathogenic and lead to UTIs (Gerges-Knafl et al., 2020).
Conditions
- Urinary Infection
Sponsors & Collaborators
-
University Hospital, Rouen
lead OTHER
Principal Investigators
-
Sandrine SD DAHYOT, Doctor · University Rouen Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-09
- Primary Completion
- 2025-03-07
- Completion
- 2025-04-10
Countries
- France
Study Locations
More Related Trials
-
Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?
NCT02292160 ·Status: COMPLETED
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)
NCT07012421 ·Status: RECRUITING
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
NCT02847065 ·Status: COMPLETED
-
Study of the Intestinal Microbiota
NCT07058961 ·Status: RECRUITING
-
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
NCT02482051 ·Status: COMPLETED
-
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
NCT07313865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares
NCT00976638 ·Status: COMPLETED ·Phase: NA
-
Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital
NCT06173440 ·Status: RECRUITING
-
Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
NCT05153824 ·Status: RECRUITING
-
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 ·Status: UNKNOWN
-
Spectrum of Bacterial Infections in Rheumatology
NCT05007405 ·Status: COMPLETED
-
Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France
NCT02799225 ·Status: COMPLETED
-
Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards
NCT00520715 ·Status: COMPLETED
-
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
NCT01345929 ·Status: COMPLETED ·Phase: PHASE3
-
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 ·Status: COMPLETED
-
Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study
NCT04196387 ·Status: COMPLETED
-
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP
NCT02364284 ·Status: COMPLETED
-
Urinary Tract Infections Caused by ESBL-producing Enterobacteria
NCT03501901 ·Status: COMPLETED
-
Clinical Evaluation of Beta-Lacta ™ Test in Urinary Infections
NCT02897609 ·Status: COMPLETED
-
Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit
NCT04528043 ·Status: COMPLETED
-
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450 ·Status: COMPLETED
-
Study of Human Microbiota in Healthy and Pathological Conditions
NCT03460392 ·Status: UNKNOWN